Device Trial Radar · NCT03805243
Evaluation of the Signals Electrophysiological Measured by Intelligent Textiles
Last checked: Nov 19, 2026Latest source record: Nov 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Nov 29, 2019
Primary completion
Dec 21, 2020
Study completion Dec 21, 2020
Sponsor
- Lead sponsor
- BioSerenityNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 15, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
BioSerenity suggests developing innovative solutions, from intelligent clothes which can be used in a hospital environment or at home. These textiles allow, in particular, to measure the biophysiological signals while letting to the participant the freedom pursue its daily activities. BioSerenity has already developed two wearable wireless and portable medical devices: cardioskin with textile ECG electrods , and the Neuronaute with textile EEG, EMG electrods. The aim of the study is to test these sensors to optimize their signal to integrate them in future Bioserenity devices like a somnonaute to help diagnosis of sleep disorders, like uronaute to help diagnosis of urination disorders, like toconaute to help monitoring of pregnancy. Others CE-marked sensors developed by others manufacturers will be tested to choose those that will be integrated in the Bioserenity devices.
Conditions
- Healthy
Interventions
test of sensors for somnonaute deviceDevice
test of sensors
test of sensors for uronaute deviceDevice
test of sensors
test of sensors for toconaute deviceDevice
test of sensors
test of sensors for neuronaute deviceDevice
test of sensors
test of sensors for cardioskin deviceDevice
test of sensors
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensor quality validationTime frame: 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institut Du Cerveau Et de La Moelle Epiniere
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.